TY  - GEN
AU  - Acevedo-Gadea,Carlos
AU  - Hatzis,Christos
AU  - Chung,Gina
AU  - Fishbach,Neal
AU  - Lezon-Geyda,Kimberly
AU  - Zelterman,Daniel
AU  - DiGiovanna,Michael P
AU  - Harris,Lyndsay
AU  - Abu-Khalaf,Maysa M
TI  - Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
SN  - 1573-7217
PY  - 2015///1120
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Leukocytes, Mononuclear
KW  - metabolism
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplastic Cells, Circulating
KW  - Receptor, ErbB-2
KW  - Retreatment
KW  - Sirolimus
KW  - administration & dosage
KW  - TOR Serine-Threonine Kinases
KW  - Trastuzumab
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10549-015-3292-8
ER  -